Variant report
Variant | esv3384954 |
---|---|
Chromosome Location | chr22:29805452-29807700 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182864470 | chr22:29805487-29805488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150538747 | chr22:29805551-29805552 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556644929 | chr22:29805615-29805616 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371593592 | chr22:29805620-29805621 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs13058114 | chr22:29805622-29805623 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs539538256 | chr22:29805664-29805665 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559237453 | chr22:29805670-29805671 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577501805 | chr22:29805689-29805690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188664127 | chr22:29805746-29805747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560013797 | chr22:29805771-29805772 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574996615 | chr22:29805811-29805812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1963292 | chr22:29805867-29805868 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs563295116 | chr22:29805884-29805885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530957555 | chr22:29805885-29805886 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552243308 | chr22:29806003-29806004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563973840 | chr22:29806013-29806014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs114307286 | chr22:29806018-29806019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201011671 | chr22:29806019-29806020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192370754 | chr22:29806039-29806040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139491624 | chr22:29806044-29806045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184046633 | chr22:29806105-29806106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535343582 | chr22:29806121-29806122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs188581959 | chr22:29806129-29806130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142073843 | chr22:29806131-29806132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141132381 | chr22:29806132-29806133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs377127083 | chr22:29806163-29806164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs372227316 | chr22:29806179-29806180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550644436 | chr22:29806197-29806198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376449756 | chr22:29806204-29806205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs6006127 | chr22:29806217-29806218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs5763214 | chr22:29806222-29806223 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs539579505 | chr22:29806232-29806233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12157611 | chr22:29806259-29806260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192341766 | chr22:29806262-29806263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572944021 | chr22:29806270-29806271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201147266 | chr22:29806274-29806275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12157738 | chr22:29806277-29806278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs202171421 | chr22:29806281-29806282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12157385 | chr22:29806283-29806284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535233340 | chr22:29806289-29806290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs6006128 | chr22:29806293-29806294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553248562 | chr22:29806294-29806295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs6006129 | chr22:29806295-29806296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs66715066 | chr22:29806305-29806306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542155414 | chr22:29806307-29806308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12157390 | chr22:29806326-29806327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12158622 | chr22:29806332-29806333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12157411 | chr22:29806338-29806339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568553147 | chr22:29806345-29806346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71196663 | chr22:29806346-29806347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
abnormal development | 18461090 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 21183584 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 19521646 | CNVD |
Schizophrenia | 18990708 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Autism | 17322880 | CNVD |
Breast cancer | 20409316 | CNVD |
Neurofibromatosis type 2 | 19566914 | CNVD |
Autism | 19384346 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:29804400-29805800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
2 | chr22:29804400-29806000 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr22:29804800-29805600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr22:29805000-29805600 | Enhancers | Primary B cells from cord blood | blood |
5 | chr22:29805000-29805600 | Enhancers | Primary B cells from peripheral blood | blood |
6 | chr22:29805400-29805600 | Enhancers | GM12878-XiMat | blood |
7 | chr22:29805400-29807000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr22:29805600-29806600 | Weak transcription | Primary B cells from cord blood | blood |
9 | chr22:29805600-29806800 | Weak transcription | Primary B cells from peripheral blood | blood |
10 | chr22:29805600-29806800 | Weak transcription | GM12878-XiMat | blood |
11 | chr22:29805600-29807200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr22:29805800-29807200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
13 | chr22:29806000-29807000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
14 | chr22:29806600-29808800 | Enhancers | Primary B cells from cord blood | blood |
15 | chr22:29806800-29809200 | Enhancers | Primary B cells from peripheral blood | blood |
16 | chr22:29806800-29810400 | Enhancers | GM12878-XiMat | blood |
17 | chr22:29807000-29808400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
18 | chr22:29807000-29809000 | Enhancers | Primary monocytes fromperipheralblood | blood |
19 | chr22:29807200-29807800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
20 | chr22:29807200-29808400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |